Market Cap (In TWD)
8.13 Billion
Revenue (In TWD)
1.78 Billion
Net Income (In TWD)
-639.89 Million
Avg. Volume
1 Million
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 19.15-33.75
- PE
- -
- EPS
- -
- Beta Value
- 0.459
- ISIN
- TW0004142005
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Chi-Hsien Chan
- Employee Count
- -
- Website
- https://www.adimmune.com.tw
- Ipo Date
- 2012-05-03
- Details
- Adimmune Corporation manufactures and sells human vaccines in Taiwan. It offers AdimFlu-S, a quadrivalent influenza vaccine; tetanus toxoid alum precipitated product that is used for the prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent influenza vaccines; Quadrivalent influenza vaccine; Influenza A (H1N1) Virus Monovalent Vaccine; Tetanus Toxoid; and purified Tuberculin, as well as contract manufacturing services. The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its name to Adimmune Corporation in 2001. Adimmune Corporation was founded in 1965 and is headquartered in Taichung, Taiwan.
More Stocks
-
002774IFE Elevators Co., Ltd.
002774
-
HPR
-
2284
-
3IINFOLTD3i Infotech Limited
3IINFOLTD
-
OXBOFOxford BioDynamics Plc
OXBOF
-
NORNQ
-
FGREiffage SA
FGR
-
7110Kurashicom Inc.
7110